181 related articles for article (PubMed ID: 16081688)
21. Analysis of TEL proteins in human leukemias.
Poirel H; Lacronique V; Mauchauffé M; Le Coniat M; Raffoux E; Daniel MT; Erickson P; Drabkin H; MacLeod RA; Drexler HG; Ghysdael J; Berger R; Bernard OA
Oncogene; 1998 Jun; 16(22):2895-903. PubMed ID: 9671410
[TBL] [Abstract][Full Text] [Related]
22. E2a/Pbx1 oncogene inhibits terminal differentiation but not myeloid potential of pro-T cells.
Bourette RP; Grasset MF; Mouchiroud G
Oncogene; 2007 Jan; 26(2):234-47. PubMed ID: 16819510
[TBL] [Abstract][Full Text] [Related]
23. The TEL-AML1 fusion protein of acute lymphoblastic leukemia modulates IRF3 activity during early B-cell differentiation.
de Laurentiis A; Hiscott J; Alcalay M
Oncogene; 2015 Dec; 34(49):6018-28. PubMed ID: 25893288
[TBL] [Abstract][Full Text] [Related]
24. TEL-AML1 promotes development of specific hematopoietic lineages consistent with preleukemic activity.
Morrow M; Horton S; Kioussis D; Brady HJ; Williams O
Blood; 2004 May; 103(10):3890-6. PubMed ID: 14726384
[TBL] [Abstract][Full Text] [Related]
25. ETV6-NCOA2 fusion induces T/myeloid mixed-phenotype leukemia through transformation of nonthymic hematopoietic progenitor cells.
Fishman H; Madiwale S; Geron I; Bari V; Van Loocke W; Kirschenbaum Y; Ganmore I; Kugler E; Rein-Gil A; Friedlander G; Schiby G; Birger Y; Strehl S; Soulier J; Knoechel B; Ferrando A; Noy-Lotan S; Nagler A; Mulloy JC; Van Vlierberghe P; Izraeli S
Blood; 2022 Jan; 139(3):399-412. PubMed ID: 34624096
[TBL] [Abstract][Full Text] [Related]
26. TEL-AML1, expressed from t(12;21) in human acute lymphocytic leukemia, induces acute leukemia in mice.
Bernardin F; Yang Y; Cleaves R; Zahurak M; Cheng L; Civin CI; Friedman AD
Cancer Res; 2002 Jul; 62(14):3904-8. PubMed ID: 12124316
[TBL] [Abstract][Full Text] [Related]
27. Occurrence of TEL-AML1 fusion resulting from (12;21) translocation in human early B-lineage leukemia cell lines.
Uphoff CC; MacLeod RA; Denkmann SA; Golub TR; Borkhardt A; Janssen JW; Drexler HG
Leukemia; 1997 Mar; 11(3):441-7. PubMed ID: 9067587
[TBL] [Abstract][Full Text] [Related]
28. Signal transduction and transforming properties of the TEL-TRKC fusions associated with t(12;15)(p13;q25) in congenital fibrosarcoma and acute myelogenous leukemia.
Liu Q; Schwaller J; Kutok J; Cain D; Aster JC; Williams IR; Gilliland DG
EMBO J; 2000 Apr; 19(8):1827-38. PubMed ID: 10775267
[TBL] [Abstract][Full Text] [Related]
29. The ETS factor TEL2 is a hematopoietic oncoprotein.
Carella C; Potter M; Bonten J; Rehg JE; Neale G; Grosveld GC
Blood; 2006 Feb; 107(3):1124-32. PubMed ID: 16234363
[TBL] [Abstract][Full Text] [Related]
30. Meis2 as a critical player in MN1-induced leukemia.
Lai CK; Norddahl GL; Maetzig T; Rosten P; Lohr T; Sanchez Milde L; von Krosigk N; Docking TR; Heuser M; Karsan A; Humphries RK
Blood Cancer J; 2017 Sep; 7(9):e613. PubMed ID: 28960191
[TBL] [Abstract][Full Text] [Related]
31. The Tel-PDGFRbeta fusion gene produces a chronic myeloproliferative syndrome in transgenic mice.
Ritchie KA; Aprikyan AA; Bowen-Pope DF; Norby-Slycord CJ; Conyers S; Bartelmez S; Sitnicka EH; Hickstein DD
Leukemia; 1999 Nov; 13(11):1790-803. PubMed ID: 10557054
[TBL] [Abstract][Full Text] [Related]
32. [Advance of study on MN1 gene in acute myeloid leukemia - review].
Sun HM; Qian SX; Li JY
Zhongguo Shi Yan Xue Ye Xue Za Zhi; 2009 Apr; 17(2):504-8. PubMed ID: 19379599
[TBL] [Abstract][Full Text] [Related]
33. TEL/AML1 shows dominant-negative effects over TEL as well as AML1.
Gunji H; Waga K; Nakamura F; Maki K; Sasaki K; Nakamura Y; Mitani K
Biochem Biophys Res Commun; 2004 Sep; 322(2):623-30. PubMed ID: 15325275
[TBL] [Abstract][Full Text] [Related]
34. Expression levels of TEL, AML1, and the fusion products TEL-AML1 and AML1-TEL versus drug sensitivity and clinical outcome in t(12;21)-positive pediatric acute lymphoblastic leukemia.
Stams WA; den Boer ML; Beverloo HB; Meijerink JP; van Wering ER; Janka-Schaub GE; Pieters R
Clin Cancer Res; 2005 Apr; 11(8):2974-80. PubMed ID: 15837750
[TBL] [Abstract][Full Text] [Related]
35. High MN1 expression increases the in vitro clonogenic activity of primary mouse B-cells.
Numata M; Yener MD; Ekmekçi SS; Aydın M; Grosveld G; Cardone M; Terranova S; Geltink RK; Özbek U; Özçelik E; Güleç Ç; Anak S; Karaman S; Öztürk G; Akbıyık M; Kandilci A
Leuk Res; 2015 Aug; 39(8):906-12. PubMed ID: 26111797
[TBL] [Abstract][Full Text] [Related]
36. The Tel-Abl (ETV6-Abl) tyrosine kinase, product of complex (9;12) translocations in human leukemia, induces distinct myeloproliferative disease in mice.
Million RP; Aster J; Gilliland DG; Van Etten RA
Blood; 2002 Jun; 99(12):4568-77. PubMed ID: 12036890
[TBL] [Abstract][Full Text] [Related]
37. Cbf beta-SMMHC induces distinct abnormal myeloid progenitors able to develop acute myeloid leukemia.
Kuo YH; Landrette SF; Heilman SA; Perrat PN; Garrett L; Liu PP; Le Beau MM; Kogan SC; Castilla LH
Cancer Cell; 2006 Jan; 9(1):57-68. PubMed ID: 16413472
[TBL] [Abstract][Full Text] [Related]
38. Mll fusions generated by Cre-loxP-mediated de novo translocations can induce lineage reassignment in tumorigenesis.
Drynan LF; Pannell R; Forster A; Chan NM; Cano F; Daser A; Rabbitts TH
EMBO J; 2005 Sep; 24(17):3136-46. PubMed ID: 16096649
[TBL] [Abstract][Full Text] [Related]
39. Similar MLL-associated leukemias arising from self-renewing stem cells and short-lived myeloid progenitors.
Cozzio A; Passegué E; Ayton PM; Karsunky H; Cleary ML; Weissman IL
Genes Dev; 2003 Dec; 17(24):3029-35. PubMed ID: 14701873
[TBL] [Abstract][Full Text] [Related]
40. Transforming property of TEL-FGFR3 mediated through PI3-K in a T-cell lymphoma that subsequently progressed to AML.
Maeda T; Yagasaki F; Ishikawa M; Takahashi N; Bessho M
Blood; 2005 Mar; 105(5):2115-23. PubMed ID: 15514005
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
